Showing results (91-100 of 106) with videos related to
Sort By:
Pageof 11
Clinical Therapeutics|September 1, 1996
A review of health-related quality-of-life measures used in end-stage renal diseaseE T Edgell, S J Coons, W B Carter, et al.Clinical Therapeutics|October 26, 2000
Development of subscales from the symptoms/problems and effects of kidney disease scales of the kidney disease quality of life instrumentS Rao, W B Carter, D L Mapes, et al.Science (New York, N.Y.)|November 19, 2011
Ultralight metallic microlatticesT A Schaedler, A J Jacobsen, A Torrents, et al.Medical Care|December 1, 1979
Effects of a self-administered health history on new-patient visits in a general medical clinicT S Inui, R A Jared, W B Carter, et al.Diabetes|June 1, 1990
Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humansP C Butler, J Chou, W B Carter, et al.British Journal of Cancer|July 17, 1999
Activity and regulation by growth factors of calmodulin-dependent protein kinase III (elongation factor 2-kinase) in human breast cancerT G Parmer, M D Ward, E J Yurkow, et al.Toxicology|June 30, 2000
Comparison of respiratory responses to Metarhizium anisopliae extract using two different sensitization protocolsM D Ward, S L Madison, D L Andrews, et al.Cancer|December 18, 2001
Delivering adjuvant chemotherapy to women with early-stage breast carcinoma: current patterns of careB K Link, G T Budd, S Scott, et al.Virology|July 1, 1988
Nucleotide sequence of the envelope protein genes of a highly virulent, neurotropic strain of Newcastle disease virusU M Schaper, F J Fuller, M D Ward, et al.Clinical Lymphoma|November 15, 2001
The impact of age on delivered dose intensity and hospitalizations for febrile neutropenia in patients with intermediate-grade non-Hodgkin's lymphoma receiving initial CHOP chemotherapy: a risk factor analysisV A Morrison, V Picozzi, S Scott, et al.Pageof 11